To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Non-Departmental Publication (Guidance and Regulation)
UK Health Security Agency

Apr. 22 2024

Source Page: National coding taxonomy for incident learning in clinical imaging, MRI and nuclear medicine
Document: (Excel)

Found: Safety checks2.1c) Contraindication or allergy checks 2.1.


Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 10 October 2022
Document: Freedom of Information request (FOI 22/960) (PDF)

Found: Allergy The prevalence of allergy in patients with NPs has been reported as varying from 10% (Delaney


Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 12 (PDF)

Found: Version: MedDRA 25.0 Reaction Name TotalFatal Immune system disorders Allergic conditions NEC Allergy


Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/996) - attachment 3 (PDF)

Found: Version: MedDRA 25.0 Reaction Name TotalFatal Immune system disorders Allergic conditions NEC Allergy


Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 7 November 2022
Document: Freedom of Information request (FOI 22/1069) - attachment 2 (PDF)

Found: Version: MedDRA 25.0 Reaction Name TotalFatal Immune system disorders Allergic conditions NEC Allergy


Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 14 November 2022
Document: Freedom of Information request (FOI 22/951) - attachment 3 (PDF)

Found: Version: MedDRA 25.0 Reaction Name TotalFatal Immune system disorders Allergic conditions NEC Allergy


Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022
Document: Freedom of Information request (FOI 22/1107) - attachment 3 (PDF)

Found: Version: MedDRA 25.1 Reaction Name TotalFatal Immune system disorders Allergic conditions NEC Allergy


Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 5 December 2022
Document: FOI 22/1102 - attachment 1 (PDF)

Found: Version: MedDRA 25.0 Reaction Name TotalFatal Immune system disorders Allergic conditions NEC Allergy


Select Committee
Scientific Advisory Committee on Nutrition
FDO0142 - Food, Diet and Obesity

Written Evidence May. 29 2024

Inquiry: Food, Diet and Obesity
Inquiry Status: Closed
Committee: Food, Diet and Obesity Committee

Found: Specialised formula, including low- allergy formula, are also usually not required after the first


Written Question
General Practitioners: Allergies
Thursday 7th September 2023

Asked by: Martyn Day (Scottish National Party - Linlithgow and East Falkirk)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department has made a recent assessment of the (a) adequacy and (b) availability of allergy training for GPs.

Answered by Neil O'Brien

We have made no assessment. General practitioners (GPs) are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by the National Institute for Care Excellence, to ensure that they can continue to provide high-quality care to all patients.

All UK registered doctors are expected to meet the professional standards set out in the General Medical Council’s (GMC’s) Good Medical Practice. In 2012, the GMC introduced revalidation which supports doctors in regularly reflecting on how they can develop or improve their practice. This gives patients confidence doctors are up to date with their practice and promotes improved quality of care by driving improvements in clinical governance.

The training curricula for postgraduate trainee doctors is set by the relevant medical Royal College and has to meet the standards set by the GMC. The Royal College of General Practitioners has developed an allergy e-learning online resource to support their continuing professional development which aims to educate GPs about the various presentations of allergic disease.